PatternsRadar
Sign in

ARTEMISMEDArtemis Medicare Services Limited

NSE
Full chart
318.35INR-5.75 (-1.77%)Close · 6 Oct 2026
3 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹5,040 CrMarket cap
44.2P/E (TTM)
49.6%Delivery

Filings & corporate actions

28 results filed
CSV
Next results · Q2 FY27
Expected 27 Oct 2026 – 14 Nov 2026
Estimate: filed 27–45 days after quarter end, last 5 times
Dividend
₹0.45 per share · last 10 Jul 2026
2026
  • 3 AugresultsResults · Q1 FY27 · consolidated and standalone-0.1%NSE
  • 15 JulshareholdingShareholding · 30 Jun 2026+1.9%NSE
  • 10 JuldividendDividend · ₹0.45 per share+3.4%
  • 8 MayresultsResults · Q4 FY26 · consolidated and standalone+5.8%NSE
  • 14 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
  • 2 FebresultsResults · Q3 FY26 · consolidated and standalone-9.2%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-3.7%NSE

Reaction to results · all yearsrose on day 0 in 10 of 27 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY273 Aug 2026-0.1%+3.7%+8.5%2.4×
Q4 FY268 May 2026+5.8%+2.6%-2.8%4.3×
Q3 FY262 Feb 2026-9.2%-1.6%-2.5%5.9×
Q2 FY2611 Nov 2025+6.8%+14.1%+9.1%13.7×
Q1 FY265 Aug 2025-0.9%-3.2%-8.8%1.6×
Q4 FY2512 May 2025-2.1%-1.0%+4.6%2.1×
Q3 FY255 Feb 2025-1.9%-7.1%-19.6%1.3×
Q2 FY2514 Nov 20240.0%+14.5%+16.9%2.3×
Q1 FY258 Aug 2024-0.5%+1.2%+12.5%0.8×
Q4 FY2410 May 2024+1.4%+7.4%+0.7%1.2×
Q3 FY245 Feb 2024-4.1%-10.1%-10.5%1.7×
Q2 FY249 Nov 2023+1.3%+4.1%+6.8%0.9×
Q1 FY249 Aug 2023+1.2%-1.4%+11.6%1.0×
Q4 FY235 May 2023+8.1%+11.3%+13.6%3.2×
Q3 FY232 Feb 2023-4.5%+1.0%-4.1%3.3×
Q2 FY2310 Nov 2022-2.2%-5.9%+4.0%1.4×
Q1 FY2312 Aug 2022+7.1%+11.2%+21.5%2.9×
Q4 FY2212 May 2022-1.9%+13.0%+15.5%1.1×
Q3 FY222 Feb 2022-4.5%+2.8%-12.6%1.9×
Q2 FY2227 Oct 2021-2.5%-2.1%-5.9%0.8×
Q1 FY226 Aug 2021-5.1%-9.2%-7.8%5.8×
Q4 FY2111 May 2021+4.6%+6.7%+19.6%4.0×
Q3 FY215 Feb 2021+3.5%+7.0%+8.5%2.3×
Q2 FY216 Nov 2020-2.2%-1.6%+42.5%0.2×
Q1 FY214 Aug 2020-5.1%-1.4%-4.9%3.8×
Q4 FY2023 May 2020+3.8%+16.0%+39.2%3.2×
Q3 FY205 Feb 2020-0.4%-6.2%-28.1%—
Average-0.1%+2.4%+4.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+12.7%
Profit YoY+48.3%
Interest cost YoY—
Revenue QoQ+2.9%
Profit QoQ+3.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open324.25
Day range314.25 – 324.95
52-week range203.35 – 378.80
From 52w high-16.0%
RSI (14)42.0
ATR (14)15.98
Volume4.29L
Avg volume (20D)14.93L
Rel volume0.29×
Volatility (1Y)37.0%
Turnover₹13.6Cr
SMA 50 / 200324.67 / 270.14

Delivery percentage

Latest · 6 Oct 202649.6%
20-day avg43.0%
1-year avg53.4%
Percentile (own history)18th
Range8.2–100.0%
Sessions1,654

Over the last 20 sessions ARTEMISMED settled 43.0% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 53.4%, so recent sessions are running 10.4 points lower than usual. The latest session ranks higher than 18% of the 1,654 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-1.77%-13.00%-0.47%+16.61%+41.99%+37.21%

Valuation

CSV
Market cap₹5,040 Cr
P/E (TTM)44.2
EPS (TTM)7.20
Shares outstanding15.83Cr
Listed23 Jan 2020

Ownership

CSV
Promoter58.39%
Promoter Δ QoQ0.00 pp
Public41.61%
FII12.29%
DII2.40%
Pledged44.53%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)274.7272.4279.2287.3
YoY chg——+16.4%+12.7%
Net profit (₹ Cr)30.022.230.331.4
YoY chg——+32.1%+48.3%
Net margin10.9%8.2%10.8%10.9%
EPS1.891.411.901.98

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 58.39% · public 41.61%
30 Sept 2021: promoter 69.82%31 Dec 2021: promoter 69.82%31 Mar 2022: promoter 69.82%30 Jun 2022: promoter 69.59%30 Sept 2022: promoter 69.27%31 Dec 2022: promoter 68.92%31 Mar 2023: promoter 68.92%30 Jun 2023: promoter 68.03%30 Sept 2023: promoter 68.03%31 Dec 2023: promoter 68.03%31 Mar 2024: promoter 68.03%30 Jun 2024: promoter 67.51%30 Sept 2024: promoter 67.17%31 Dec 2024: promoter 67.17%31 Mar 2025: promoter 67.17%30 Jun 2025: promoter 66.53%30 Sept 2025: promoter 66.53%15 Nov 2025: promoter 58.43%31 Dec 2025: promoter 58.39%31 Mar 2026: promoter 58.39%30 Jun 2026: promoter 58.39%
2021-092026-06
  • Promoter
  • Public and others
Promoter
58.39%
Public
41.61%
Promoter change
0.00 pp
Filed
15 Jul 2026
FII
12.29%
DII
2.40%
Promoter pledged
44.53%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations225.0218.8225.2223.2241.4232.4239.9255.0274.7272.4279.2287.3
Other income2.41.81.94.47.48.812.36.97.77.57.85.4
Total income227.4220.6227.1227.6248.9241.2252.2261.9282.4279.8287.0292.7
Total expenses208.6204.3206.9206.0218.3214.4223.6232.1243.0247.0246.8250.1
└ Finance costs7.98.08.68.18.08.07.87.47.26.76.46.5
└ Depreciation10.010.211.010.811.211.511.711.211.712.412.812.7
Profit before tax18.816.320.221.630.626.828.729.839.429.840.342.6
Tax expense5.34.85.95.18.46.25.78.69.47.510.011.2
Net profit13.511.614.316.522.120.622.921.230.022.230.331.4
EPS1.000.851.041.141.421.321.471.351.901.411.901.98
Net margin6.02%5.28%6.35%7.40%9.17%8.86%9.56%8.31%10.92%8.16%10.84%10.94%
PBT margin8.35%7.45%8.98%9.69%12.66%11.54%11.95%11.68%14.33%10.93%14.42%14.84%
Tax rate27.98%29.17%29.32%23.64%27.57%23.17%20.03%28.83%23.81%25.30%24.77%26.24%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 3 Aug 2026.

ARTEMISMED at a glance

  • ARTEMISMED closed at ₹318.35 on 6 Oct 2026, -1.77% on the day, +37.2% over one year, 16.0% below its 52-week high of ₹378.8.
  • Delivery was 49.6% of traded quantity on 6 Oct 2026, the 18th percentile of its own 1,654 sessions with a reading (20-session average 43.0%, 1-year average 53.4%).
  • Market capitalisation is ₹5,040 crore at a trailing P/E of 44.2 (trailing EPS ₹7.2).
  • Q1 FY27 results (consolidated, filed 3 Aug 2026): revenue ₹287 crore (+12.7% year on year), net profit ₹31 crore (+48.3%); the price moved -0.1% on the first session after.
  • Promoters held 58.39% at 30 Jun 2026, unchanged on the previous filing, with 44.53% of promoter shares pledged.
  • Q2 FY27 results are expected between 27 Oct 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE025R01021
SeriesEQ
Listed23 Jan 2020
History from24 Jan 2020
Sessions1,660
Turnover rank#470

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE